Table 1. Proteins complexes produced using the strategy described.
Protein | Stabilized by | Strategy | References | |
---|---|---|---|---|
Human steroid nuclear receptors | ERα-E | Ligand (oestrogen) | Ligand in cell culture | 14 |
Thioredoxin fusion | Keep Thioredoxin (TRX) fusion for crystallization | 33 | ||
3Cys to Ser mutations | Mutations mimic the conformational changes induced by the ligand | 13 | ||
ERβ-EF | TIF2 (623–772) | In vitro reconstitution (co-cell lysis) | This article | |
GRtm-E | TIF2 (623–772) and solubility mutant | In cell co-expression | This article | |
HIV-1 pre-integration complexes | IN | hLEDGF | In vitro reconstitution (dialysis) | 12 |
hLEDGF/hINI1(174–289) | 11 | |||
hLEDGF | Expression in E. coli, insect and mammalian cells and in vitro reconstitution | This article |
ER, human estradiol (E2) nuclear receptor; IN, integrase; TIF2, transcriptional intermediary factor 2.